 Bennett Davenport
Concepts (205)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD8-Positive T-Lymphocytes | 5 | 2021 | 506 | 1.650 |
Why?
| | Chikungunya virus | 6 | 2022 | 42 | 1.640 |
Why?
| | Chikungunya Fever | 5 | 2022 | 43 | 1.470 |
Why?
| | Epitopes, T-Lymphocyte | 3 | 2021 | 141 | 1.080 |
Why?
| | Lymph Nodes | 4 | 2021 | 334 | 1.040 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 68 | 0.850 |
Why?
| | Alphavirus Infections | 4 | 2021 | 37 | 0.810 |
Why?
| | Joints | 1 | 2020 | 63 | 0.810 |
Why?
| | Lymphocytic choriomeningitis virus | 2 | 2018 | 17 | 0.800 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2018 | 9 | 0.770 |
Why?
| | Immunologic Memory | 2 | 2018 | 239 | 0.700 |
Why?
| | Viral Envelope Proteins | 2 | 2022 | 71 | 0.420 |
Why?
| | Mice | 14 | 2022 | 11250 | 0.410 |
Why?
| | Receptors, Immunologic | 2 | 2021 | 147 | 0.400 |
Why?
| | Aging | 1 | 2018 | 1238 | 0.400 |
Why?
| | Peromyscus | 2 | 2004 | 10 | 0.360 |
Why?
| | Adaptive Immunity | 2 | 2020 | 122 | 0.360 |
Why?
| | Animals | 18 | 2022 | 25325 | 0.320 |
Why?
| | Antiviral Agents | 2 | 2021 | 471 | 0.300 |
Why?
| | Chemokines | 3 | 2020 | 181 | 0.300 |
Why?
| | Mice, Transgenic | 6 | 2021 | 1499 | 0.290 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 3 | 2014 | 243 | 0.270 |
Why?
| | Mice, Inbred C57BL | 8 | 2021 | 3748 | 0.270 |
Why?
| | Ross River virus | 2 | 2021 | 21 | 0.260 |
Why?
| | Kupffer Cells | 2 | 2021 | 41 | 0.260 |
Why?
| | Lectins, C-Type | 2 | 2020 | 61 | 0.250 |
Why?
| | Interferon Type I | 2 | 2021 | 104 | 0.250 |
Why?
| | Genomic Islands | 1 | 2022 | 10 | 0.250 |
Why?
| | Viral Vaccines | 1 | 2022 | 57 | 0.230 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2020 | 769 | 0.230 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2021 | 271 | 0.220 |
Why?
| | Virus Replication | 2 | 2022 | 332 | 0.220 |
Why?
| | Immunization | 2 | 2020 | 264 | 0.220 |
Why?
| | Viremia | 1 | 2021 | 104 | 0.220 |
Why?
| | Antibodies, Viral | 2 | 2022 | 411 | 0.220 |
Why?
| | Receptors, Mitogen | 1 | 2020 | 4 | 0.210 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2022 | 213 | 0.210 |
Why?
| | O'nyong-nyong Virus | 1 | 2019 | 4 | 0.200 |
Why?
| | Arthritis | 1 | 2020 | 68 | 0.200 |
Why?
| | Adoptive Transfer | 1 | 2020 | 183 | 0.200 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2018 | 20 | 0.180 |
Why?
| | Antigens, Viral | 1 | 2018 | 120 | 0.180 |
Why?
| | Engineering | 7 | 2018 | 47370 | 0.180 |
Why?
| | Social Responsibility | 7 | 2018 | 47385 | 0.180 |
Why?
| | Attitude | 7 | 2018 | 47516 | 0.180 |
Why?
| | Students | 7 | 2018 | 47688 | 0.180 |
Why?
| | Dendritic Cells | 1 | 2021 | 353 | 0.180 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2018 | 56 | 0.180 |
Why?
| | Cytokines | 2 | 2020 | 1416 | 0.170 |
Why?
| | Disease Models, Animal | 3 | 2020 | 2840 | 0.160 |
Why?
| | TRPM Cation Channels | 2 | 2008 | 53 | 0.160 |
Why?
| | Cells, Cultured | 3 | 2018 | 3092 | 0.160 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2018 | 429 | 0.150 |
Why?
| | Cell Survival | 1 | 2018 | 865 | 0.150 |
Why?
| | Monocytes | 1 | 2017 | 372 | 0.150 |
Why?
| | Acute Lung Injury | 1 | 2017 | 200 | 0.140 |
Why?
| | Cell Movement | 1 | 2018 | 649 | 0.140 |
Why?
| | Insulin-Secreting Cells | 1 | 2018 | 234 | 0.140 |
Why?
| | Vaccination | 1 | 2021 | 704 | 0.140 |
Why?
| | Glucose | 1 | 2018 | 580 | 0.140 |
Why?
| | Nuclear Proteins | 1 | 2018 | 473 | 0.130 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2013 | 126 | 0.120 |
Why?
| | Neutrophils | 1 | 2017 | 947 | 0.120 |
Why?
| | Epithelial Cells | 1 | 2017 | 740 | 0.120 |
Why?
| | MicroRNAs | 1 | 2017 | 455 | 0.120 |
Why?
| | Muscle, Skeletal | 1 | 2020 | 1036 | 0.120 |
Why?
| | Gene Expression Regulation | 2 | 2018 | 1914 | 0.110 |
Why?
| | Transcription Factors | 1 | 2018 | 1184 | 0.110 |
Why?
| | Mice, Knockout | 3 | 2022 | 2075 | 0.100 |
Why?
| | Male | 9 | 2020 | 90667 | 0.100 |
Why?
| | Immunodominant Epitopes | 1 | 2009 | 23 | 0.100 |
Why?
| | Female | 8 | 2020 | 92196 | 0.090 |
Why?
| | Humans | 16 | 2020 | 128242 | 0.090 |
Why?
| | Virulence | 2 | 2021 | 183 | 0.090 |
Why?
| | Parkinsonian Disorders | 1 | 2008 | 32 | 0.090 |
Why?
| | Mutant Proteins | 1 | 2008 | 86 | 0.090 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2008 | 43 | 0.090 |
Why?
| | Lymphocyte Activation | 2 | 2018 | 816 | 0.090 |
Why?
| | Socialization | 7 | 2018 | 47368 | 0.090 |
Why?
| | Interviews as Topic | 7 | 2018 | 47819 | 0.090 |
Why?
| | Curriculum | 7 | 2018 | 47915 | 0.090 |
Why?
| | Longitudinal Studies | 7 | 2018 | 49312 | 0.090 |
Why?
| | Surveys and Questionnaires | 7 | 2018 | 50539 | 0.090 |
Why?
| | Viral Load | 2 | 2021 | 368 | 0.090 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2004 | 109 | 0.090 |
Why?
| | Young Adult | 7 | 2018 | 55149 | 0.090 |
Why?
| | Adolescent | 7 | 2018 | 60563 | 0.080 |
Why?
| | Cloning, Molecular | 2 | 2004 | 423 | 0.080 |
Why?
| | T-Lymphocytes | 2 | 2014 | 1281 | 0.080 |
Why?
| | Adult | 7 | 2018 | 70001 | 0.080 |
Why?
| | Lung | 1 | 2017 | 2582 | 0.080 |
Why?
| | Insulin | 2 | 2018 | 1537 | 0.080 |
Why?
| | Peptide Fragments | 1 | 2009 | 562 | 0.070 |
Why?
| | Immune Sera | 1 | 2004 | 57 | 0.070 |
Why?
| | Hemocyanins | 1 | 2004 | 63 | 0.070 |
Why?
| | Antigen-Presenting Cells | 1 | 2004 | 123 | 0.070 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2004 | 100 | 0.070 |
Why?
| | Antigen Presentation | 1 | 2004 | 140 | 0.070 |
Why?
| | Interleukin-2 | 1 | 2004 | 285 | 0.070 |
Why?
| | Bone Marrow Cells | 1 | 2004 | 235 | 0.070 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2004 | 263 | 0.060 |
Why?
| | Cell Line, Tumor | 2 | 2020 | 2097 | 0.060 |
Why?
| | Salmonella | 1 | 2022 | 34 | 0.060 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2022 | 44 | 0.060 |
Why?
| | Interferon Regulatory Factors | 1 | 2022 | 19 | 0.060 |
Why?
| | T-Lymphocyte Subsets | 1 | 2004 | 334 | 0.060 |
Why?
| | Phenylalanine | 1 | 2022 | 43 | 0.060 |
Why?
| | Alphavirus | 1 | 2021 | 15 | 0.060 |
Why?
| | Vaccines, Attenuated | 1 | 2022 | 72 | 0.060 |
Why?
| | Cell Proliferation | 2 | 2018 | 1671 | 0.060 |
Why?
| | Protein Domains | 1 | 2022 | 136 | 0.060 |
Why?
| | Mice, Mutant Strains | 1 | 2021 | 215 | 0.060 |
Why?
| | Oxidative Stress | 2 | 2022 | 873 | 0.060 |
Why?
| | Viral Nonstructural Proteins | 1 | 2021 | 45 | 0.050 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 385 | 0.050 |
Why?
| | Single-Cell Analysis | 1 | 2021 | 157 | 0.050 |
Why?
| | Cricetinae | 1 | 2020 | 212 | 0.050 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 235 | 0.050 |
Why?
| | Chemokine CCL21 | 1 | 2018 | 7 | 0.050 |
Why?
| | Venules | 1 | 2018 | 11 | 0.050 |
Why?
| | Organelle Biogenesis | 1 | 2018 | 7 | 0.050 |
Why?
| | Lymphoid Tissue | 1 | 2018 | 43 | 0.050 |
Why?
| | RNA, Viral | 1 | 2021 | 423 | 0.050 |
Why?
| | Conserved Sequence | 2 | 2009 | 173 | 0.050 |
Why?
| | Ovalbumin | 1 | 2018 | 116 | 0.050 |
Why?
| | Tissue Culture Techniques | 1 | 2018 | 47 | 0.050 |
Why?
| | Mitochondrial Dynamics | 1 | 2018 | 21 | 0.050 |
Why?
| | Interferon Regulatory Factor-7 | 1 | 2017 | 4 | 0.050 |
Why?
| | Heparin-binding EGF-like Growth Factor | 1 | 2017 | 9 | 0.050 |
Why?
| | Interferon Regulatory Factor-3 | 1 | 2017 | 12 | 0.050 |
Why?
| | Stromal Cells | 1 | 2018 | 86 | 0.050 |
Why?
| | Lysine | 1 | 2019 | 181 | 0.050 |
Why?
| | Antigens, Ly | 1 | 2017 | 31 | 0.040 |
Why?
| | Receptors, CCR2 | 1 | 2017 | 21 | 0.040 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 956 | 0.040 |
Why?
| | Mutation, Missense | 1 | 2019 | 236 | 0.040 |
Why?
| | RNA Transport | 1 | 2017 | 18 | 0.040 |
Why?
| | Diphtheria Toxin | 1 | 2017 | 59 | 0.040 |
Why?
| | Cadaver | 1 | 2018 | 179 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2021 | 417 | 0.040 |
Why?
| | Bacterial Proteins | 1 | 2022 | 549 | 0.040 |
Why?
| | Luminescent Proteins | 1 | 2018 | 132 | 0.040 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2017 | 83 | 0.040 |
Why?
| | Protein Subunits | 1 | 2018 | 180 | 0.040 |
Why?
| | Magnesium | 2 | 2008 | 108 | 0.040 |
Why?
| | Arenaviridae Infections | 1 | 2016 | 7 | 0.040 |
Why?
| | Cell Degranulation | 1 | 2016 | 27 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 233 | 0.040 |
Why?
| | Epitopes | 1 | 2018 | 314 | 0.040 |
Why?
| | Granzymes | 1 | 2016 | 32 | 0.040 |
Why?
| | Mutation | 2 | 2021 | 2524 | 0.040 |
Why?
| | RNA Interference | 1 | 2018 | 369 | 0.040 |
Why?
| | Cell Communication | 1 | 2017 | 202 | 0.040 |
Why?
| | Macrophages | 1 | 2022 | 955 | 0.040 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2016 | 170 | 0.040 |
Why?
| | Oxygen Consumption | 1 | 2018 | 449 | 0.040 |
Why?
| | Immunity, Innate | 1 | 2021 | 539 | 0.040 |
Why?
| | Cellular Senescence | 1 | 2016 | 117 | 0.040 |
Why?
| | Recombinant Fusion Proteins | 1 | 2018 | 506 | 0.040 |
Why?
| | Killer Cells, Natural | 1 | 2017 | 267 | 0.040 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2009 | 2293 | 0.040 |
Why?
| | V(D)J Recombination | 1 | 2014 | 5 | 0.040 |
Why?
| | Nanoparticles | 1 | 2017 | 257 | 0.030 |
Why?
| | Cell Membrane | 2 | 2008 | 537 | 0.030 |
Why?
| | B-Lymphocytes | 1 | 2018 | 610 | 0.030 |
Why?
| | Pneumonia | 1 | 2017 | 405 | 0.030 |
Why?
| | Thymus Gland | 1 | 2014 | 207 | 0.030 |
Why?
| | Amino Acid Sequence | 2 | 2008 | 1637 | 0.030 |
Why?
| | Viruses | 1 | 2013 | 60 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2008 | 2277 | 0.030 |
Why?
| | Transcriptome | 1 | 2016 | 511 | 0.030 |
Why?
| | Rats | 1 | 2018 | 4631 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2016 | 1332 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2013 | 866 | 0.030 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 2009 | 25 | 0.020 |
Why?
| | Epitope Mapping | 1 | 2009 | 39 | 0.020 |
Why?
| | Amino Acids, Diamino | 1 | 2008 | 1 | 0.020 |
Why?
| | Guam | 1 | 2008 | 3 | 0.020 |
Why?
| | Adenosine Diphosphate Ribose | 1 | 2008 | 7 | 0.020 |
Why?
| | Hybridomas | 1 | 2009 | 177 | 0.020 |
Why?
| | Signal Transduction | 1 | 2021 | 3482 | 0.020 |
Why?
| | Ion Channel Gating | 1 | 2008 | 62 | 0.020 |
Why?
| | Inflammation | 1 | 2017 | 1666 | 0.020 |
Why?
| | Proline | 1 | 2008 | 55 | 0.020 |
Why?
| | Leucine | 1 | 2008 | 75 | 0.020 |
Why?
| | Bacteria | 1 | 2013 | 490 | 0.020 |
Why?
| | Mice, Inbred NOD | 1 | 2009 | 452 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2008 | 221 | 0.020 |
Why?
| | Calcium Signaling | 1 | 2008 | 178 | 0.020 |
Why?
| | Autoantigens | 1 | 2009 | 290 | 0.020 |
Why?
| | Temperature | 1 | 2008 | 471 | 0.020 |
Why?
| | Genetic Complementation Test | 1 | 2005 | 50 | 0.020 |
Why?
| | Evolution, Molecular | 1 | 2008 | 323 | 0.020 |
Why?
| | Gene Deletion | 1 | 2005 | 270 | 0.020 |
Why?
| | Protein Binding | 1 | 2009 | 1545 | 0.020 |
Why?
| | Models, Molecular | 1 | 2008 | 1180 | 0.020 |
Why?
| | Cell Division | 1 | 2005 | 638 | 0.020 |
Why?
| | DNA, Complementary | 1 | 2004 | 221 | 0.020 |
Why?
| | Calcium | 1 | 2008 | 857 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2004 | 284 | 0.020 |
Why?
| | Homeostasis | 1 | 2005 | 410 | 0.020 |
Why?
| | Interleukins | 1 | 2004 | 181 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 778 | 0.010 |
Why?
| | Phosphorylation | 1 | 2005 | 1283 | 0.010 |
Why?
| | Cell Line | 1 | 2005 | 2191 | 0.010 |
Why?
|
|
Davenport's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|